Signature Estate & Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
SO
WT
Signature Estate & Investment Advisors's XBI Position: Q2 2026 in Review
Signature Estate & Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 2,361 shares — an estimated $302K sold.
Signature Estate & Investment Advisors first reported a position in XBI in Q2 2016 and held it in 20 quarters. The position peaked at $701K in Q3 2018. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Signature Estate & Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
- Signature Estate & Investment Advisors sold 2,361 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $302K.
- Signature Estate & Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 20 quarters.
- Signature Estate & Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $701K in Q3 2018.
- 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.